The presence of metabolic syndrome may be a factor in whose control improvements persist, and may negatively affect asthma control, as one trial showed that those with metabolic syndrome at baseline and during follow-up (i.e., their metabolic syndrome did not resolve with surgery) had the highest risk for losing asthma control at subsequent visits, with the findings statistically significant even when adjusting for weight loss [82]
A population-based study in Catalonia
Glutathione S-transferase (GST) has been proposed as a target for the development of novel antimalarials (Salinas and Wong, 1999
The addiction circuit, an unexpected branch The brain effects extend beyond memory and motor disease
Some patients come in occasionally for recovery, while others schedule regular sessions for ongoing wellness support
In PIONEER 4, additional anti-diabetic medication and rescue medication use was more than double in the placebo treatment group compared to the semaglutide 14 mg and LIRA 1.8 mg treatment groups